Ludvik B - Search Results

1

Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects.

Ludvik B, Hanefeld M, Pacini G. Ludvik B, et al. Diabetes Obes Metab. 2008 Jul;10(7):586-92. doi: 10.1111/j.1463-1326.2007.00752.x. Epub 2007 Jul 21. Diabetes Obes Metab. 2008. PMID: 17645559 Clinical Trial.

2

Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects.

Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R. Kautzky-Willer A, et al. Among authors: ludvik b. Metabolism. 1992 Dec;41(12):1304-12. doi: 10.1016/0026-0495(92)90100-o. Metabolism. 1992. PMID: 1461136

3

The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension.

Ludvik B, Kueenburg E, Brunnbauer M, Schernthaner G, Prager R. Ludvik B, et al. J Cardiovasc Pharmacol. 1991;18 Suppl 2:S157-9. J Cardiovasc Pharmacol. 1991. PMID: 1725031

4

Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.

Ludvik B, Lell B, Hartter E, Schnack C, Prager R. Ludvik B, et al. Diabetes. 1991 Dec;40(12):1615-9. doi: 10.2337/diab.40.12.1615. Diabetes. 1991. PMID: 1756902

5

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.

Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R. Hartter E, et al. Among authors: ludvik b. Diabetologia. 1991 Jan;34(1):52-4. doi: 10.1007/BF00404025. Diabetologia. 1991. PMID: 2055340

6

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.

Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J. Ludvik B, et al. Diabetes. 1995 Sep;44(9):1121-5. doi: 10.2337/diab.44.9.1121. Diabetes. 1995. PMID: 7657038

7

Intravenous calcitriol normalizes insulin sensitivity in uremic patients.

Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R. Kautzky-Willer A, et al. Among authors: ludvik b. Kidney Int. 1995 Jan;47(1):200-6. doi: 10.1038/ki.1995.24. Kidney Int. 1995. PMID: 7731147

8

Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.

Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R. Ludvik B, et al. J Clin Invest. 1994 Nov;94(5):2045-50. doi: 10.1172/JCI117558. J Clin Invest. 1994. PMID: 7962550 Free PMC article.

9

Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhäusl W, Prager R. Kautzky-Willer A, et al. Among authors: ludvik b. Diabetologia. 1994 Feb;37(2):188-94. doi: 10.1007/s001250050092. Diabetologia. 1994. PMID: 8163054

10

Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans.

Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R. Ludvik B, et al. Diabetologia. 1993 Jan;36(1):84-7. doi: 10.1007/BF00399099. Diabetologia. 1993. PMID: 8436259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results